MIM
RIGL icon

Marco Investment Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Marco Investment Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,000
Closed -$60K – 211
2022
Q1 		$60K Hold
2,000
– – 0.01% 208
2021
Q4 		$53K Buy
+2,000
New +$60.3K 0.01% 220
2018
Q4 		– Sell
-2,700
Closed -$87K – 187
2018
Q3 		$87K Buy
+2,700
New +$81K 0.01% 186

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marco Investment Management's RIGL Position: Q2 2022 in Review

Marco Investment Management sold out of Rigel Pharmaceuticals (RIGL) in Q2 2022, closing a stake of 2,000 shares — an estimated $60K sold.

Marco Investment Management first reported a position in RIGL in Q3 2018 and held it in 3 quarters. The position peaked at $87K in Q3 2018. 135 funds tracked by Wall St. Rank hold RIGL as of Q2 2022.

  • Marco Investment Management reported no remaining Rigel Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Marco Investment Management sold 2,000 Rigel Pharmaceuticals shares in Q2 2022, an estimated $60K.
  • Marco Investment Management first reported a position in Rigel Pharmaceuticals in Q3 2018 and held it in 3 quarters.
  • Marco Investment Management's Rigel Pharmaceuticals position peaked at $87K in Q3 2018.
  • 135 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2022.

Based on Marco Investment Management's 13F filing for Q2 2022, filed 5 Aug 2022.